Larsen Michael Due, Schou Mette, Kristiansen Anja Sparre, Hallas Jesper
Faculty of Health Sciences, Institute of Public Health, Clinical Pharmacology, University of Southern Denmark, J. B. Winsløwsvej 19, 2. sal, Odense M, 5000, Denmark,
Eur J Clin Pharmacol. 2014 Jul;70(7):859-65. doi: 10.1007/s00228-014-1681-2. Epub 2014 Apr 27.
This study had two aims: Firstly, to describe how prescriptions for proton pump inhibitor (PPI) in primary care were influenced by a change of the hospital drug policy, and secondly, to describe if a large discount on an expensive PPI (esomeprazole) to a hospital would influence prescribing patterns after discharge.
This register study was conducted at Odense University Hospital, Denmark, and by use of pharmacy dispensing data and a hospital-based pharmacoepidemiological database, the medication regimens of patients were followed across hospitalisation. The influence of hospital drug policy on prescribings in primary care was measured by the likelihood of having a high-cost PPI prescribed before and after change of drug policy.
In total, 9,341 hospital stays in 2009 and 2010 were included. The probability of a patient to be prescribed an expensive PPI after discharge decreased from 33.5 to 9.4%, corresponding to a risk ratio of 0.28. In primary care after discharge, 13.4% of esomeprazole use was initiated in the hospital, and this was 8.4% for PPIs in general. After the change of hospital drug policy, this decreased to 6.5% for esomeprazole and increased for the recommended PPIs pantoprazole and lansoprazole to 14.6 and 26.1%, respectively. The effect of a large discount on expensive PPI to hospital was 14.7%, and this decreased to 2.6% when coordinating drug policy in hospital and primary care.
The likelihood of having an expensive PPI prescribed after hospital stay decreased when coordinating drug policy and the influence of a large discount to hospital could be minimised.
本研究有两个目的:第一,描述初级保健中质子泵抑制剂(PPI)的处方如何受到医院药物政策变化的影响;第二,描述医院对昂贵的PPI(埃索美拉唑)大幅折扣是否会影响出院后的处方模式。
本登记研究在丹麦欧登塞大学医院进行,通过药房配药数据和基于医院的药物流行病学数据库,对患者的用药方案进行住院期间跟踪。通过药物政策改变前后开具高成本PPI的可能性来衡量医院药物政策对初级保健处方的影响。
总共纳入了2009年和2010年的9341次住院病例。出院后患者被开具昂贵PPI的概率从33. %降至9.4%,相应的风险比为0.28。在出院后的初级保健中,13.4%的埃索美拉唑使用是在医院开始的,一般PPI的这一比例为8.4%。医院药物政策改变后,埃索美拉唑的这一比例降至6.5%,而推荐的PPI泮托拉唑和兰索拉唑分别增至14.6%和26.1%。医院对昂贵PPI大幅折扣的影响为14.7%,当医院和初级保健协调药物政策时,这一比例降至2.6%。
协调药物政策时,住院后开具昂贵PPI的可能性降低,且对医院大幅折扣的影响可降至最低。